Received Nov 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
has had major surgery; This non-serious case was reported by a consumer via call center representative and described the occurrence of surgery in a female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced surgery (Verbatim: has had major surgery). The outcome of the surgery was unknown. It was unknown if the reporter considered the surgery to be related to Arexvy. It was unknown if the company considered the surgery to be related to Arexvy. Additional Information: GSK receipt date: 23-OCT-2025 The patient stated that she had a reaction to Arexvy but could not remember what type of reaction she had. She could not provide the date of the vaccination. The patient would not provide her date of birth as she said "company already had it." She stated that she had sent company a list of medications and a diagnosis list in March, and that her doctor had sent her a consent form. Historically, the patient had a lot of adverse reactions that affected her everyday life. She had major surgery and was once in a walker. The patient would not provide further details. The patient provided consent to follow up with her HCP.